AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28239939 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sitagliptin 100 mg plus fasiglifam 50 mg
Number of subjects: 368
Study 28239939 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin 100 mg
Number of subjects: 368
Study 28239939 — intervention group
Group type: COMPARATOR
Intervention: Fasiglifam 25 mg monotherapy
Number of subjects: 368
Study 28239939 — intervention group
Group type: COMPARATOR
Intervention: Fasiglifam 50 mg monotherapy
Number of subjects: 368
Study 25806587 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Vascular Occlusion (PVO) during rest
Number of subjects: 12
Study 25806587 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Vascular Occlusion (PVO) during low-intensity resistance exercise (LIRE: 30% 1RM)
Number of subjects: 12
Study 25806587 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity resistance exercise (MIRE: 70% 1RM) without PVO
Number of subjects: 12
Study 25806587 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Vascular Occlusion (PVO) during moderate-intensity resistance exercise (MIRE)
Number of subjects: 12
Study 22298417 — intervention group
Group type: EXPERIMENTAL
Intervention: Online CBT
Number of subjects: 105
Study 22298417 — intervention group
Group type: COMPARATOR
Intervention: Bibliotherapy
Number of subjects: 105
Study 22298417 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 105
Study 21083640 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 3189
Study 21083640 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 3189
Study 19543068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine withdrawal (WDL)
Number of subjects: 489
Study 19543068 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine and prednisolone (AP)
Number of subjects: 489
Study 19543068 — intervention group
Group type: COMPARATOR
Intervention: Long-term cyclosporine alone (Cy)
Number of subjects: 489
Study 17276718 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine administered at dinner (n=589)
Number of subjects: 1178
Study 17276718 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine administered at bedtime (n=589)
Number of subjects: 1178
Study 17276718 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine at dinner (FAA subgroup)
Number of subjects: 1178
Study 17276718 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine at bedtime (FAA subgroup)
Number of subjects: 1178
Study 17276718 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine at dinner (RHI subgroup)
Number of subjects: 1178
Study 17276718 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine at bedtime (RHI subgroup)
Number of subjects: 1178
Study 17276718 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 1178
Study 14996038 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance of Wakefulness Test (MWT)
Number of subjects: 151
Study 14996038 — intervention group
Group type: EXPERIMENTAL
Intervention: MWT/ESS discrepancy score (MED)
Number of subjects: 151
Study 14996038 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 151
Study 11317534 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast conserving treatment (quandrantectomy + radiation)
Number of subjects: 190
Study 11317534 — intervention group
Group type: COMPARATOR
Intervention: Modified radical mastectomy
Number of subjects: 190
Study 11317534 — intervention group
Group type: EXPERIMENTAL
Intervention: Localization of tumors (lateral, medial, central)
Number of subjects: 190
Study 9681665 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical aspirin/diethyl ether (ADE) mixture (750 mg)
Number of subjects: 19
Study 9681665 — intervention group
Group type: COMPARATOR
Intervention: Oral aspirin (500 mg)
Number of subjects: 19
Study 7927958 — intervention group
Group type: EXPERIMENTAL
Intervention: Policosanol 5 mg once-a-day for 8 weeks
Number of subjects: 22
Study 7927958 — intervention group
Group type: EXPERIMENTAL
Intervention: Policosanol 5 mg twice-a-day for 8 weeks
Number of subjects: 22
Study 7927958 — intervention group
Group type: EXPERIMENTAL
Intervention: Policosanol 10 mg twice-a-day for 8 weeks
Number of subjects: 22
Study 7927958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 2502890 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) therapy, 5 doses every other day, 60-min intravenous infusion
Number of subjects: 6
Study 2502890 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) therapy
Number of subjects: 6
Study 1097985 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin
Number of subjects: 52
Study 1097985 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B
Number of subjects: 52
Study 1097985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 30948446 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC) exercise
Number of subjects: 0
Study 31182623 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumpstart Mirror Trainer
Number of subjects: 47
Study 31182623 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirroprep
Number of subjects: 47
Study 31182623 — intervention group
Group type: COMPARATOR
Intervention: Control device
Number of subjects: 47
Study 27807755 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills group intervention consisting of 32, 2-hour sessions
Number of subjects: 15
Study 27807755 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 15
Study 26277231 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope
Number of subjects: 151
Study 26277231 — intervention group
Group type: COMPARATOR
Intervention: Macintosh/Miller blades
Number of subjects: 151
Study 26277231 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider type (attendings)
Number of subjects: 151
Study 26277231 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider type (certified registered nurse anesthetists)
Number of subjects: 151
Study 26277231 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider type (third‐year clinical anesthesia residents)
Number of subjects: 151
Study 26277231 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex (men)
Number of subjects: 151
Study 26277231 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex (women)
Number of subjects: 151
Study 23544678 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM)
Number of subjects: 393
Study 23544678 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 393
Study 21300618 — intervention group
Group type: COMPARATOR
Intervention: HPV infections (types 16, 18, 31, 33, 35, 45, 52, 58, 59)
Number of subjects: 0
Study 21300618 — intervention group
Group type: COMPARATOR
Intervention: HPV infections (types 16, 18, 31)
Number of subjects: 0
Study 21300618 — intervention group
Group type: COMPARATOR
Intervention: HPV infections (type 59)
Number of subjects: 0
Study 21300618 — intervention group
Group type: COMPARATOR
Intervention: HPV infections (type 33)
Number of subjects: 0
Study 21300618 — intervention group
Group type: COMPARATOR
Intervention: HPV infections (types 16, 33)
Number of subjects: 0
Study 19590481 — intervention group
Group type: EXPERIMENTAL
Intervention: Active electrical stimulation of acupuncture points on the wrist, 30 minutes, 2 times/week for 4 weeks.
Number of subjects: 60
Study 19590481 — intervention group
Group type: COMPARATOR
Intervention: Sham electrical stimulation of acupuncture points on the wrist, 30 minutes, 2 times/week for 4 weeks.
Number of subjects: 60
Study 19590481 — intervention group
Group type: EXPERIMENTAL
Intervention: Active electrical stimulation of acupuncture points on the wrist
Number of subjects: 60
Study 19590481 — intervention group
Group type: COMPARATOR
Intervention: Sham electrical stimulation of acupuncture points on the wrist
Number of subjects: 60
Study 16982499 — intervention group
Group type: EXPERIMENTAL
Intervention: Training Group (TG) - 6-month extracurricular training programme (two 50-min sessions per week) involving moderate-intensity impact exercises
Number of subjects: 370
Study 16982499 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - No training programme
Number of subjects: 370
Study 12221048 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose almonds (73±3 g/d)
Number of subjects: 27
Study 12221048 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose almonds
Number of subjects: 27
Study 12221048 — intervention group
Group type: COMPARATOR
Intervention: Low-saturated fat whole-wheat muffins
Number of subjects: 27
Study 12221048 — intervention group
Group type: COMPARATOR
Intervention: Control diet (whole-wheat muffins)
Number of subjects: 27
Study 10878510 — intervention group
Group type: COMPARATOR
Intervention: Phenoxymethylpenicillin (40‐60 mg/kg/day) for 10 days (n = 28)
Number of subjects: 51
Study 10878510 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin‐clavulanic acid (20‐40 mg/kg/day) for 10 days (n = 23)
Number of subjects: 51
Study 7793184 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.13 mg.kg‐1)
Number of subjects: 60
Study 7793184 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental (4 mg.kg‐1)
Number of subjects: 60
Study 7793184 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.13 mg.kg‐1) combined with Flumazenil (6 micrograms.kg‐1)
Number of subjects: 60
Study 1954178 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian irradiation shortly after mastectomy (experimental group)
Number of subjects: 346
Study 1954178 — intervention group
Group type: COMPARATOR
Intervention: Ovarian irradiation planned for the time of first recurrence (control group)
Number of subjects: 346
Study 7004999 — intervention group
Group type: EXPERIMENTAL
Intervention: Motilin infusion of 0.2 pmol/kg/min
Number of subjects: 7
Study 7004999 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline (control)
Number of subjects: 7
Study 7004999 — intervention group
Group type: EXPERIMENTAL
Intervention: Motilin infusion
Number of subjects: 7
Study 6143184 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation therapy alone (group A)
Number of subjects: 60
Study 6143184 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation plus biofeedback (group B)
Number of subjects: 60
Study 6143184 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 29790430 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 set resistance training (G1S)
Number of subjects: 62
Study 29790430 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 sets resistance training (G3S)
Number of subjects: 62
Study 29790430 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 62
Study 25917895 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment with Saccharomyces boulardii (n = 15)
Number of subjects: 33
Study 25917895 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (n = 18)
Number of subjects: 33
Study 24417471 — intervention group
Group type: EXPERIMENTAL
Intervention: At-risk drinkers
Number of subjects: 2779
Study 24417471 — intervention group
Group type: COMPARATOR
Intervention: Not-at-risk drinkers
Number of subjects: 2779
Study 21457354 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 20
Study 21457354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 20736449 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily for 14 days
Number of subjects: 15
Study 20736449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 18515817 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (one suction device)
Number of subjects: 2
Study 18515817 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (two suction devices)
Number of subjects: 2
Study 16030100 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly weight training (0 to 12 months)
Number of subjects: 85
Study 16030100 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment group (no exercise for 6 months, then training for 6 months)
Number of subjects: 85
Study 12441750 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal circulation
Number of subjects: 23
Study 12441750 — intervention group
Group type: COMPARATOR
Intervention: No extracorporeal circulation
Number of subjects: 23
Study 10521838 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-mosaic findings of trisomies 13, 18, and 21
Number of subjects: 20527
Study 10521838 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosaic findings of trisomies 13, 18, and 21
Number of subjects: 20527
Study 10521838 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct preparations and cultured cells
Number of subjects: 20527
Study 10521838 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosaicism for aneuploidies at CVS
Number of subjects: 20527
Study 7738952 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Assessment Questionnaire (HAQ)
Number of subjects: 100
Study 7738952 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Analog Scale (VAS) for pain
Number of subjects: 100
Study 7738952 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Clinical Score (TCS)
Number of subjects: 100
Study 7738952 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms of TOS
Number of subjects: 100
Study 7738952 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory findings
Number of subjects: 100
Study 7738952 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive factors
Number of subjects: 100
Study 2074162 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium (Nxs) 550 mg twice each day by mouth
Number of subjects: 40
Study 2074162 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 40
Study 7018862 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (dosage not specified)
Number of subjects: 0
Study 7018862 — intervention group
Group type: COMPARATOR
Intervention: Antacid (specific type not mentioned)
Number of subjects: 0
Study 30606161 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messages about the availability of oral HIV self-test kits sent three times to the intervention group.
Number of subjects: 2262
Study 30606161 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard of care (SOC) - text messages about HIV testing in general sent three times.
Number of subjects: 2262
Study 30606161 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) - text messages about HIV testing in general sent one time.
Number of subjects: 2262
Study 28240689 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized budesonide/formoterol
Number of subjects: 61
Study 28240689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 26355952 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed water‐soluble egg membrane (WSEM), 450 mg daily
Number of subjects: 25
Study 26355952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 23542892 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist-taught physical education (PE) classes (100 min·wk-1)
Number of subjects: 708
Study 23542892 — intervention group
Group type: COMPARATOR
Intervention: Control group (general classroom teachers conducting PE)
Number of subjects: 708
Study 23542892 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist-taught PE
Number of subjects: 708
Study 23542892 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 708
Study 20644971 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek™ Silorane (low‐shrinkage silorane‐based composite)
Number of subjects: 72
Study 20644971 — intervention group
Group type: COMPARATOR
Intervention: CeramX™ (methacrylate‐based composite)
Number of subjects: 72
Study 20027498 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant Hepatitis B vaccine (VrHB‐IB)
Number of subjects: 1024
Study 20027498 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant Hepatitis B vaccine (VrHB‐IB) with increased antigen concentration to 25 microg
Number of subjects: 1024
Study 20027498 — intervention group
Group type: COMPARATOR
Intervention: Control (reference vaccine)
Number of subjects: 1024
Study 17285408 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 186
Study 17285408 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 186
Study 15712730 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-event method (whole signal acquired through an A/D converter)
Number of subjects: 0
Study 15712730 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time method (interface between electrocardiograph and computer for real-time processing)
Number of subjects: 0
Study 15712730 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 12782208 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg aspartame
Number of subjects: 6
Study 12782208 — intervention group
Group type: EXPERIMENTAL
Intervention: 176 mg aspartic acid + 224 mg phenylalanine
Number of subjects: 6
Study 12782208 — intervention group
Group type: COMPARATOR
Intervention: 400 mg corn flour (control)
Number of subjects: 6
Study 10396563 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser phonosurgery
Number of subjects: 44
Study 10396563 — intervention group
Group type: COMPARATOR
Intervention: Conventional cold phonosurgery
Number of subjects: 44
Study 7676242 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin plus clavulanic acid
Number of subjects: 87
Study 7676242 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin plus gentamicin
Number of subjects: 87
Study 1673971 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg
Number of subjects: 0
Study 1673971 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 10 mg
Number of subjects: 0
Study 1673971 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 20 mg
Number of subjects: 0
Study 1673971 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50 mg
Number of subjects: 0
Study 6128741 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg quazepam
Number of subjects: 57
Study 6128741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 29581107 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplant center-based patient navigator
Number of subjects: 401
Study 27046668 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD Coach app
Number of subjects: 49
Study 27046668 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 49
Study 22974139 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular embolectomy employing the Merci Retriever or the Penumbra System
Number of subjects: 120
Study 22974139 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 120
Study 22030088 — intervention group
Group type: EXPERIMENTAL
Intervention: 200-mg twice daily celecoxib
Number of subjects: 1647
Study 22030088 — intervention group
Group type: EXPERIMENTAL
Intervention: 400-mg twice daily celecoxib
Number of subjects: 1647
Study 22030088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1647
Study 22030088 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of 200-mg twice daily celecoxib
Number of subjects: 1647
Study 22030088 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of 400-mg twice daily celecoxib
Number of subjects: 1647
Study 22030088 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent use of low-dose aspirin
Number of subjects: 1647
Study 20356526 — intervention group
Group type: EXPERIMENTAL
Intervention: Streamlined Liner of the Pharynx Airway (SLIPA)
Number of subjects: 90
Study 17884846 — intervention group
Group type: EXPERIMENTAL
Intervention: Transport with tirofiban (10 microg/kg bolus i.v. + i.v. infusion 0.1 microg/kg/min) for primary PCI
Number of subjects: 401
Study 17884846 — intervention group
Group type: COMPARATOR
Intervention: On-site thrombolysis
Number of subjects: 401
Study 17884846 — intervention group
Group type: EXPERIMENTAL
Intervention: Transport with tirofiban
Number of subjects: 401
Study 15699690 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro gliadin challenge in biopsy cultures of CD children on GFD (group 1)
Number of subjects: 32
Study 15699690 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo gluten challenge in 24 CD children
Number of subjects: 32
Study 15699690 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 2) with no gliadin challenge
Number of subjects: 32
Study 12744577 — intervention group
Group type: EXPERIMENTAL
Intervention: Real ECT treatment
Number of subjects: 20
Study 12744577 — intervention group
Group type: COMPARATOR
Intervention: Simulated ECT treatment (Control)
Number of subjects: 20
Study 9831872 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 24
Study 9831872 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 24
Study 9160584 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin 0.2 microgram/kg
Number of subjects: 10
Study 9160584 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin 0.6 microgram/kg
Number of subjects: 10
Study 9160584 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin 1.0 microgram/kg
Number of subjects: 10
Study 9160584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9160584 — intervention group
Group type: EXPERIMENTAL
Intervention: Social interaction task
Number of subjects: 10
Study 2912330 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (4 micrograms/kg/min given intravenously)
Number of subjects: 17
Study 2912330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 30796112 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% Basal Rate Reduction (BRR) set 90 min pre-exercise
Number of subjects: 17
Study 30796112 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% Basal Rate Reduction (BRR) set 90 min pre-exercise
Number of subjects: 17
Study 30796112 — intervention group
Group type: COMPARATOR
Intervention: Pump Suspension (PS) at exercise onset
Number of subjects: 17
Study 28434463 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal yoga (20-week intervention with two weekly 70-min yoga sessions led by a certified midwife)
Number of subjects: 94